[MMCCORP] YoY Annual (Unaudited) Result on 31-Dec-2009 [#4]

Stock
[MMCCORP] MMC CORPORATION BHD
Announcement Date
24-Feb-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Dec-2009 [#4]
Profit Trend
YoY- -57.75%
Quarter Report
Latest QR
Upcoming QR
MMCCORP's Result
MMCCORP's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Revenue 9,199,212 9,336,809 8,563,623 8,444,321 8,545,033 5,722,033 2,839,060 21.62%
PBT 1,808,305 998,581 555,722 681,626 1,041,069 1,018,042 581,340 20.79%
Tax -261,514 -169,308 21,670 -58,362 -124,003 -156,999 -12,677 65.53%
NP 1,546,791 829,273 577,392 623,264 917,066 861,043 568,663 18.13%
-
NP to SH 922,351 332,572 243,861 233,614 552,889 551,522 390,024 15.41%
-
Tax Rate 14.46% 16.95% -3.90% 8.56% 11.91% 15.42% 2.18% -
Total Cost 7,652,421 8,507,536 7,986,231 7,821,057 7,627,967 4,860,990 2,270,397 22.42%
-
Net Worth 7,034,180 6,275,401 5,967,188 6,281,945 6,157,135 5,865,634 4,140,769 9.22%
Dividend
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Div 137,029 121,852 106,556 91,042 76,202 76,177 137,010 0.00%
Div Payout % 14.86% 36.64% 43.70% 38.97% 13.78% 13.81% 35.13% -
Equity
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Net Worth 7,034,180 6,275,401 5,967,188 6,281,945 6,157,135 5,865,634 4,140,769 9.22%
NOSH 3,045,100 3,046,311 3,044,483 3,034,756 3,048,086 1,523,541 1,522,341 12.23%
Ratio Analysis
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
NP Margin 16.81% 8.88% 6.74% 7.38% 10.73% 15.05% 20.03% -
ROE 13.11% 5.30% 4.09% 3.72% 8.98% 9.40% 9.42% -
Per Share
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
RPS 302.10 306.50 281.28 278.25 280.34 375.57 186.49 8.36%
EPS 30.29 10.92 8.01 7.67 18.20 36.20 25.62 2.82%
DPS 4.50 4.00 3.50 3.00 2.50 5.00 9.00 -10.90%
NAPS 2.31 2.06 1.96 2.07 2.02 3.85 2.72 -2.68%
Adjusted Per Share Value based on latest NOSH - 3,079,285
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
RPS 302.10 306.62 281.23 277.31 280.62 187.91 93.23 21.62%
EPS 30.29 10.92 8.01 7.67 18.16 18.11 12.81 15.40%
DPS 4.50 4.00 3.50 2.99 2.50 2.50 4.50 0.00%
NAPS 2.31 2.0608 1.9596 2.063 2.022 1.9263 1.3598 9.22%
Price Multiplier on Financial Quarter End Date
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Date 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 29/12/06 -
Price 2.63 2.77 2.78 2.43 1.04 9.30 4.04 -
P/RPS 0.87 0.90 0.99 0.87 0.37 2.48 2.17 -14.11%
P/EPS 8.68 25.37 34.71 31.57 5.73 25.69 15.77 -9.46%
EY 11.52 3.94 2.88 3.17 17.44 3.89 6.34 10.45%
DY 1.71 1.44 1.26 1.23 2.40 0.54 2.23 -4.32%
P/NAPS 1.14 1.34 1.42 1.17 0.51 2.42 1.49 -4.36%
Price Multiplier on Announcement Date
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Date 28/02/13 29/02/12 22/02/11 24/02/10 25/02/09 27/02/08 27/02/07 -
Price 2.51 2.74 2.81 2.45 1.41 3.76 5.60 -
P/RPS 0.83 0.89 1.00 0.88 0.50 1.00 3.00 -19.26%
P/EPS 8.29 25.10 35.08 31.83 7.77 10.39 21.86 -14.90%
EY 12.07 3.98 2.85 3.14 12.86 9.63 4.58 17.51%
DY 1.79 1.46 1.25 1.22 1.77 1.33 1.61 1.78%
P/NAPS 1.09 1.33 1.43 1.18 0.70 0.98 2.06 -10.05%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment